Prospective Dutch colorectal cancer cohort: an infrastructure for long-term observational, prognostic, predictive and (randomized) intervention research

References

• Organization WH. GLOBOCAN. [2012]. Available from: http://globocan.iarc.fr/Default.aspx.
   Google Scholar
• Baca B, Beart RW Jr., Etzioni DA. Surveillance after colorectal cancer resection: a systematic review. Dis Colon Rectum 2011;54:1036–48.
   PubMed Web of Science ®Google Scholar
• Faivre J, Dancourt V, Lejeune C, et al. Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study. Gastroenterology 2004;126:1674–80.
   PubMed Web of Science ®Google Scholar
• Kapiteijn E, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. New Engl J Med 2001;345:638–46.
   PubMed Web of Science ®Google Scholar
• Lemmens VE, de Haan N, Rutten HJ, et al. Improvements in population-based survival of patients presenting with metastatic rectal cancer in the south of the Netherlands, 1992-2008. Clin Exp Metast 2011;28:283–90.
   PubMed Web of Science ®Google Scholar
• Ragnhammar P, Hafstrom L, Nygren P, et al, Care SB-gSCoTAiH. A systematic overview of chemotherapy effects in colorectal cancer. Acta Oncologica 2001;40:282–308.
   PubMed Web of Science ®Google Scholar
• van Steenbergen LN, Elferink MA, Krijnen P, et al. Improved survival of colon cancer due to improved treatment and detection: a nationwide population-based study in The Netherlands 1989-2006. Ann Oncol 2010;21:2206–12.
   PubMed Web of Science ®Google Scholar
• Gustavsson B, Carlsson G, Machover D, et al. A review of the evolution of systemic chemotherapy in the management of colorectal cancer. Clin Colorect Cancer 2015;14:1–10.
   PubMed Web of Science ®Google Scholar
• Schreuders EH, Ruco A, Rabeneck L, et al. Colorectal cancer screening: a global overview of existing programmes. Gut 2015;64:1637–49.
   PubMed Web of Science ®Google Scholar
• De Sousa EMF, Wang X, Jansen M, et al. Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions. Nature Med 2013;19:614–8.
   PubMed Web of Science ®Google Scholar
• Locker GY, Hamilton S, Harris J, et al. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol 2006;24:5313–27.
   PubMed Web of Science ®Google Scholar
• Walther A, Johnstone E, Swanton C, et al. Genetic prognostic and predictive markers in colorectal cancer. Nature Rev Cancer 2009;9:489–99.
   PubMed Web of Science ®Google Scholar
• Sinicrope FA, Okamoto K, Kasi PM, et al. Molecular Biomarkers in the Personalized Treatment of Colorectal Cancer. Clin Gastroenterol Hepatol 2016;14(5):651–8.
   PubMed Web of Science ®Google Scholar
• Korn EL, Freidlin B, Mooney M, et al. Accural experience of national cancer institute cooroperative group phase III trials activated from 2000 to 2007. J Clin Oncol 2010;35:5197–201.
   Web of Science ®Google Scholar
• Bennette CS, Ramsey SD, McDermott CL, et al. Predicting low accrual in the national cancer institute's cooperative group clinical trials. J Nat Cancer Inst 2016;108:djv324.
   PubMedGoogle Scholar
• Young RC. Cancer clinical trials-a chronic but curable crisis. New Engl J Med 2010;363:306–9.
   PubMed Web of Science ®Google Scholar
• Mol L, Koopman M, van Gils CW, et al. Comparison of treatment outcome in metastatic colorectal cancer patients included in a clinical trial versus daily practice in The Netherlands. Acta Oncologica 2013;52:950–5.
   PubMed Web of Science ®Google Scholar
• Sorbye H, Pfeiffer P, Cavalli-Bjorkman N, et al. Clinical trial enrollment, patient characteristics, and survival differences in prospectively registered metastatic colorectal cancer patients. Cancer 2009;115:4679–87.
   PubMed Web of Science ®Google Scholar
• Le DT, Uram JN, Wang H, et al. PD-1 Blockade in Tumors with Mismatch-Repair Deficiency. New Engl J Med 2015;372:2509–20.
   PubMed Web of Science ®Google Scholar
• Relton C, Torgerson D, O'cathain A, et al. Rethinking pragmatic randomised controlled trials: introducing the “cohort multiple randomised controlled trial” design. BMJ 2010;340:c1066.
   PubMed Web of Science ®Google Scholar
• von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007;370:1453–7.
   PubMed Web of Science ®Google Scholar
• Netherlands Comprehensive Cancer Organisation (IKNL). [2016, May]. Available from: https://www.iknl.nl/over-iknl/about-iknl.
   Google Scholar
• Netherlands Cancer Registry. [2016, May]. Available from: http://www.cijfersoverkanker.nl/?language=en.
   Google Scholar
• Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Nat Cancer Inst 1993;85:365–76.
   PubMed Web of Science ®Google Scholar
• Whistance RN, Conroy T, Chie W, et al. Clinical and psychometric validation of the EORTC QLQ-CR29 questionnaire module to assess health-related quality of life in patients with colorectal cancer. Eur J Cancer 2009;45:3017–26.
   PubMed Web of Science ®Google Scholar
• Postma TJ, Aaronson NK, Heimans JJ, et al. The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: the QLQ-CIPN20. Eur J Cancer 2005;41:1135–9.
   PubMed Web of Science ®Google Scholar
• Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med 2001;33:337–43.
   PubMed Web of Science ®Google Scholar
• de Zwart BC, Frings-Dresen MH, van Duivenbooden JC. Test-retest reliability of the Work Ability Index questionnaire. Occup Med (Lond) 2002;52:177–81.
   PubMed Web of Science ®Google Scholar
• Emmertsen KJ, Laurberg S. Low anterior resection syndrome score: development and validation. Of a symptom-Based Scoring System for Bowel Dysfunction after Low Anterior Resection for Rectal Cancer. Ann Surg 2012;255:922–8.
   PubMed Web of Science ®Google Scholar
• Baxter NN, Novotny PJ, Jacobson T, et al. A stoma quality of life scale. Dis Colon Rectum 2006;49:205–12.
   PubMed Web of Science ®Google Scholar
• Wendel-Vos GC, Schuit AJ, Saris WH, et al. Reproducibility and relative validity of the short questionnaire to assess health-enhancing physical activity. J Clin Epidemiol 2003;56:1163–9.
   PubMed Web of Science ®Google Scholar
• Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica 1983;67:361–70.
   PubMed Web of Science ®Google Scholar
• Smets EM, Garssen B, Bonke B, et al. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosomatic Res 1995;39:315–25.
   PubMed Web of Science ®Google Scholar
• Sangha O, Stucki G, Liang MH, et al. The self-administered comorbidity questionnaire: a new method to assess comorbidity for clinical and health services research. Arthrit Rheumat 2003;49:156–63.
   PubMed Web of Science ®Google Scholar
• van de Poll-Franse LV, Horevoorts N, van Eenbergen M, et al. The Patient Reported Outcomes Following Initial treatment and Long term Evaluation of Survivorship registry: scope, rationale and design of an infrastructure for the study of physical and psychosocial outcomes in cancer survivorship cohorts. Euro J Cancer 2011;47:2188–94.
   PubMed Web of Science ®Google Scholar
• Taichman DB, Backus J, Baethge C, et al. Sharing clinical trial data-A proposal from the international committee of medical journal editors. New Engl J Med 2016;374:384–6.
   PubMed Web of Science ®Google Scholar
• Dutch Institute for Clinical Auditing (DICA). [2016, May]. Available from: http://www.clinicalaudit.nl/about-DICA.
   Google Scholar
• Energy for life after Colorectal cancer (ENCORE). [2016, May]. Available from: http://encorestudie.nl/english/.
   Google Scholar
• Netherlands Cancer Registry . [2016, May]. Available from: https://www.iknl.nl/over-iknl/about-iknl/what.
   Google Scholar
• Winkels RM, Heine-Broring RC, van Zutphen M, et al. The COLON study: Colorectal cancer: Longitudinal, Observational study on Nutritional and lifestyle factors that may influence colorectal tumour recurrence, survival and quality of life. BMC Cancer 2014;14:374.
   PubMed Web of Science ®Google Scholar
• Young-Afat DAVH, Van Gils CH. Staged-informed consent in the cohort multiple Randomized Controlled Trial design: Rethinking patient-centered informed consent to avoid pre-randomization. Epidemiology 2016;27(3):389–92.
   PubMed Web of Science ®Google Scholar
• Burbach JP, Verkooijen HM, Intven M, et al. RandomizEd controlled trial for pre-operAtive dose-escaLation BOOST in locally advanced rectal cancer (RECTAL BOOST study): study protocol for a randomized controlled trial. Trials 2015;16:58.
   PubMed Web of Science ®Google Scholar
• Zelen M. A new design for randomized clinical trials. New Engl J Med 1979;300:1242–5.
   PubMed Web of Science ®Google Scholar
• Couwenberg AMBJ, Smits AB, van Vulpen M, et al. The impact of use of a retractor sponge on duration of hospital stay and perioperative complications in patients with colorectal cancer undergoing laparoscopic colorectal surgery: the SPONGE trial. Trials 2016;17:132.
   PubMed Web of Science ®Google Scholar
• MEDOCC. [2016, Feb. 3]. Available from: http://www.aacr.org/FUNDING/PAGES/sutc-dream-team.aspx?ItemID =15#.VrF92FK3wXh.
   Google Scholar